CA2246371A1 - Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor - Google Patents

Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor Download PDF

Info

Publication number
CA2246371A1
CA2246371A1 CA002246371A CA2246371A CA2246371A1 CA 2246371 A1 CA2246371 A1 CA 2246371A1 CA 002246371 A CA002246371 A CA 002246371A CA 2246371 A CA2246371 A CA 2246371A CA 2246371 A1 CA2246371 A1 CA 2246371A1
Authority
CA
Canada
Prior art keywords
group
mixtures
growth factor
composition according
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002246371A
Other languages
English (en)
French (fr)
Inventor
Anne Marie Carella
Paul Joseph Sagel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2246371A1 publication Critical patent/CA2246371A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002246371A 1996-02-14 1997-02-06 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor Abandoned CA2246371A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60148296A 1996-02-14 1996-02-14
US63009696A 1996-04-09 1996-04-09
US08/630,096 1996-04-09
US08/601,482 1996-04-09

Publications (1)

Publication Number Publication Date
CA2246371A1 true CA2246371A1 (en) 1997-08-21

Family

ID=27083871

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002246371A Abandoned CA2246371A1 (en) 1996-02-14 1997-02-06 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor

Country Status (6)

Country Link
EP (1) EP0881905A1 (ja)
JP (1) JPH11504049A (ja)
CN (1) CN1211189A (ja)
AU (1) AU1854297A (ja)
CA (1) CA2246371A1 (ja)
WO (1) WO1997029763A1 (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1014969E (pt) * 1997-09-09 2009-02-17 Univ Rutgers Extracto de proantocianidinas de origem vegetal eficaz para inibição da aderência a superfícies de bactérias com fímbrias de tipo p
AU1223099A (en) * 1997-11-24 1999-06-15 Zhongming Zeng Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
US6192887B1 (en) * 1998-05-19 2001-02-27 The Pennsylvania State University Broad spectrum microbicidal and spermicidal compositions and methods having activity against sexually transmitted agents including papillomaviruses
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
PL354802A1 (en) 1999-09-06 2004-02-23 Effem Foods Pty Ltd Food product and process for manufacturing same
DE19948419A1 (de) * 1999-10-07 2001-04-12 Symbio Herborn Group Gmbh & Co Tampon zur Anwendung in Körperhöhlen
SE9904289D0 (sv) 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
FI109602B (fi) 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US6521270B1 (en) * 2001-06-11 2003-02-18 The Procter & Gamble Company Compositions comprising nitrofurantoin and uva ursi
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
KR20030066902A (ko) * 2002-02-06 2003-08-14 주식회사 코리즈 레반을 포함하는 장내유산균 생육촉진 조성물
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0230042D0 (en) * 2002-12-23 2003-01-29 Britannia Pharmaceuticals Ltd Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
US20040265291A1 (en) * 2003-01-24 2004-12-30 Flora Technology Inc. Compositions and methods for restoring bacterial flora
FR2856304B1 (fr) * 2003-06-20 2006-03-03 Natural Product Consulting Composition pour la prevention des infections du systeme urinaire
US20050019379A1 (en) * 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
US7785640B2 (en) * 2004-01-16 2010-08-31 Amerilab Technologies, Inc. Effervescent composition including cranberry extract
US8110215B2 (en) * 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin
EP1600060A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and fatty acid
EP1600062A1 (en) * 2004-05-25 2005-11-30 Cognis IP Management GmbH Oral and/or topical compositions comprising prebiotics and sterols
EP1614357A1 (en) * 2004-07-10 2006-01-11 Cognis IP Management GmbH Dietary supplements comprising prebiotics and fatty acid
FR2874825B1 (fr) * 2004-09-08 2006-12-08 Genibio Sarl Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
CN101175503B (zh) * 2005-04-27 2012-12-12 深圳福诺生物技术有限公司 一种调节并保持***菌群和***酸度正常的组合物与方法
AU2006244023B2 (en) * 2005-05-11 2010-12-23 Hill's Pet Nutrition, Inc. Methods for enhancing palatability of compositions for animal consumption
US8461130B2 (en) * 2006-12-28 2013-06-11 Ezaki Glico Co., Ltd. Food containing glycogen and use thereof
CN101951922B (zh) * 2007-10-11 2013-03-20 菲尔菲德食品有限公司 治疗小肠感染的包含寡聚糖及不溶性多孔材料的制剂
US20110064706A1 (en) * 2008-01-11 2011-03-17 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend
KR101257914B1 (ko) * 2008-06-24 2013-05-06 모리나가 뉴교 가부시키가이샤 검체 중에 포함되는 미생물의 생균수 측정에 이용되는 현탁용 희석액 및 생균수 측정 방법
US20100210600A1 (en) * 2009-02-19 2010-08-19 Prelief Inc. Methods and Compositions for Treating Urogenital Disorders
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
EP2662086A1 (en) * 2012-05-08 2013-11-13 Progressare Medinvest B.V. Composition for the treatment or prevention of urinary tract infections and dosage form
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
US20180256615A1 (en) * 2015-09-29 2018-09-13 Kimberly-Clark Worldwide, Inc. Composition for maintaining lactobacillus dominance
RU2637650C2 (ru) * 2016-03-29 2017-12-05 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Композиция для профилактики заболеваний мочевыводящих путей
EP3320897A1 (en) * 2016-11-14 2018-05-16 Dompè Primary S.r.l Process for the preparation of coated cranberry granules with stable proanthocyanidine content
AU2017368922A1 (en) 2016-11-30 2019-05-30 Probioswiss Ag Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid
RU2748651C2 (ru) 2017-02-28 2021-05-28 Кимберли-Кларк Ворлдвайд, Инк. Синергическая композиция для сохранения здорового баланса микрофлоры
CN113662175B (zh) * 2021-08-16 2022-05-03 广州市沐家健康产业有限公司 一种植物基酵素液排毒养颜组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427014A1 (de) * 1984-07-21 1986-01-23 Moser, Hanspeter H., Dr.med., 3012 Langenhagen Praeparat zur prophylaxe und therapie unkomplizierter harnwegsinfekte
SU1329745A1 (ru) * 1984-10-10 1987-08-15 Ленинградский технологический институт холодильной промышленности Способ производства напитка из молочной сыворотки
SU1708342A1 (ru) * 1989-10-04 1992-01-30 Научно-производственное объединение "Аэрозоль" Крем дл ухода за кожей после брить
JPH0416163A (ja) * 1990-05-02 1992-01-21 Nippon Synthetic Chem Ind Co Ltd:The 整腸用組成物
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
US5474774A (en) * 1994-03-25 1995-12-12 Jlb, Inc. Adhesion inhibiting composition
JPH0919276A (ja) * 1995-07-06 1997-01-21 Roozu Mei:Kk 健康美容飲料

Also Published As

Publication number Publication date
AU1854297A (en) 1997-09-02
EP0881905A1 (en) 1998-12-09
CN1211189A (zh) 1999-03-17
WO1997029763A1 (en) 1997-08-21
JPH11504049A (ja) 1999-04-06

Similar Documents

Publication Publication Date Title
CA2246371A1 (en) Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
WO1997029762A1 (en) Urogenital and intestinal compositions
DE60023919T2 (de) Verbesserte topische zusammensetzungen mit extrazellulären produkten von probiotischen bakterien und verwendungen davon
CN102105132B (zh) 微生物用于治疗油性皮肤的美容应用
DE502007010071C5 (de) Verwendung einer zusammensetzung aus mineralstoffen und gegebenenfalls acetogenen und/oder butyrogenen bakterien zur vermeidung oder reduzierung von gasbildung im dickdarm eines säugetiers und dadurch bedingter abdominaler beschwerden
CN102065837B (zh) 枸杞提取物用于保持和/或恢复皮肤张力和/或紧致的用途
EP2087094B1 (en) Lactobacillus fermentum ess-1, dsm17851 and its use for the treatment and/or prevention of candidiasis and urinary tract infections
AU2008238445B2 (en) Extract of Trigonella foenum-graecum
EP2575971B1 (en) Combined plant extracts for use in the treatment of microbial infections
JP2009269922A (ja) 微生物感染を予防または制御するための共生Ｂａｃｉｌｌｕｓ芽胞の局所的使用
TWI750716B (zh) 皮膚外用組成物及其用於製備改善皮膚疾病及皮膚發炎之組成物的用途
MX2012004509A (es) Composicion externa para la piel que comprende una sal y azucar como ingredientes activos para prevenir y tratar la vaginosis y uso de la misma.
RU2671221C2 (ru) Композиции, содержащие смесь бактерий, включающую педиококк и лактобактерии, и способы для уменьшения эффектов алкоголя
KR102172224B1 (ko) 인삼 발효 추출물을 유효성분으로 함유하여 황색포도상구균에 대한 항균 활성을 갖는 조성물
EP1186295B1 (fr) Préparations pharmaceutiques contenant des extraits d'isoflavone de soja et des micro-organismes probiotiques
DE102008059070B4 (de) Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung
KR101462160B1 (ko) 감귤 유산균 발효물을 이용한 항당뇨 조성물
KR20210130870A (ko) 소금 및 아시아홀리오크충영 추출물을 포함하는 여성 청결제
DE202014101285U1 (de) Zusammensetzung zur Behandlung von Magenbeschwerden
EP4311538A1 (en) Novel skin care composition for the treatment of acne
KR102172758B1 (ko) 키토올리고당-갈산 유도체를 유효성분으로 포함하는 여드름 치료 또는 예방용 조성물
KR100892050B1 (ko) 베타글루칸 및 효모유기철을 함유하는 이유자돈 사료첨가제조성물
CN117679352A (zh) 一种生物酶基组合物、含有该组合物的降糖牙膏及其制备方法
WO2024023192A1 (en) Novel skin care composition for the treatment of acne
KR20220167244A (ko) 연교, 작약, 및 치자 추출물의 장내 미생물 환경 개선용 조성물

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead